06:07 EDT Oncolytics (ONCY) files $250M mixed securities shelf
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ONCY:
- Oncolytics Biotech Shifts Corporate Domicile to British Columbia
- Oncolytics Biotech Showcases Pelareorep as Immune-Priming Backbone With New AACR 2026 Data
- Oncolytics Highlights New Pelareorep Data in Cancer Immunotherapy
- Oncolytics to present new data on Pelareorep at AACR 2026
- Oncolytics Biotech Advances Pelareorep Into New Phase 2 Colorectal Cancer Study
